Home >> Marketplace Directory >> HTG collaborates with BMS, 6/16

HTG collaborates with BMS, 6/16

image_pdfCreate PDF

 

June 2016—HTG Molecular Diagnostics entered into a research collaboration agreement with Bristol-Myers Squibb to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types. The collaboration will use the NGS-based HTG EdgeSeq system for use in support of Bristol-Myers Squibb’s translational research activities.

HTG Molecular Diagnostics, 877-289-2615

CAP TODAY
X